NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

US National Institutes of Health (NIDA - National Institute on Drug Abuse) grant open #PAR-25-204

Response due Nov 12, 2027 · 00:00 UTC

Summary

The National Institute on Drug Abuse (NIDA), under NIH/HHS, is soliciting applications for its R25 Research Education Program targeting clinical researchers and clinicians. The program is designed to support research education initiatives in the drug abuse and addiction space. Clinical trials are explicitly not allowed under this funding opportunity. The opportunity is open for a multi-year window from November 2024 through November 2027.

What they want

NIDA is seeking applications under the R25 Research Education Program mechanism to support research education activities for clinical researchers and clinicians. The program aims to develop and deliver educational curricula or training experiences that enhance the research capabilities of clinicians in areas related to drug abuse, addiction, or related biomedical/behavioral sciences. Clinical trials are explicitly excluded from this funding opportunity (PAR-25-204).

Technical requirements

Clinical trials are not allowed under this funding mechanism
Must align with NIDA research education mission targeting clinical researchers and clinicians
Must conform to NIH R25 grant mechanism requirements

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

Extremely long open window (3 years) with rolling submissions — evaluation timelines and competitiveness dynamics are unclear
No dollar value or award ceiling disclosed in the provided text

Market context

inferred from NAICS

Educational Services

NAICS 611310

US market size: $340B
Typical award: $50K – $25M

Typical buyers

DoDVAStates

Commonly required

Accreditation

Sector-level estimate — full code lookup not yet in catalog.

NIDA Research Education Program for Clinic…

Due Nov 12

Onboard ↗